Jan. 8, 2018 – The New Jersey ban on “gifts” from the pharmaceutical industry, an administrative action finalized on Dec. 22, 2017, will go into effect on Jan. 15 of this year and will be “the first of its kind for any state” to link compliance with physician licensure and apply to physicians, not the […]
Read moreApril 12, 2012 – The Association of Clinical Researchers and Educators (ACRE) announced yesterday the publication of a study in Nature Biotechnology showing that top-tier medical journals focus on the “supposed problems from academic-industry interactions and not on the benefits,” which results in a bias against such interaction. According to an ACRE press release, the study […]
Read moreFrom Tom Sullivan’s Policy and Medicine blog: cell spy Tom Sullivan cites a recent article on industry support of CME in Clinical Pharmacology & Therapeutics and elaborates on its argument that “…some of healthcare’s greatest contributions have originated from industry-sponsored science,” and says that to eliminate the industry now would be detrimental to patients. Read […]
Read more